These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16102987)

  • 1. Effects of long term NOS inhibition on disease and the immune system in MOG induced EAE.
    Danilov AI; Jagodic M; Wiklund NP; Olsson T; Brundin L
    Nitric Oxide; 2005 Nov; 13(3):188-95. PubMed ID: 16102987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis.
    Sahrbacher UC; Lechner F; Eugster HP; Frei K; Lassmann H; Fontana A
    Eur J Immunol; 1998 Apr; 28(4):1332-8. PubMed ID: 9565373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.
    Weissert R; Wiendl H; Pfrommer H; Storch MK; Schreiner B; Barth S; Seifert T; Melms A; Dichgans J; Weller M
    J Neuroimmunol; 2003 Nov; 144(1-2):28-37. PubMed ID: 14597095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.
    Ruuls SR; Van Der Linden S; Sontrop K; Huitinga I; Dijkstra CD
    Clin Exp Immunol; 1996 Mar; 103(3):467-74. PubMed ID: 8608648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to a dysfunctional glucocorticoid receptor from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via nitric oxide-induced immunosuppression.
    Marchetti B; Morale MC; Brouwer J; Tirolo C; Testa N; Caniglia S; Barden N; Amor S; Smith PA; Dijkstra CD
    J Immunol; 2002 Jun; 168(11):5848-59. PubMed ID: 12023389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis.
    Zielasek J; Jung S; Gold R; Liew FY; Toyka KV; Hartung HP
    J Neuroimmunol; 1995 Apr; 58(1):81-8. PubMed ID: 7537283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
    Hasarmeh M; Itzik A; Weidenfeld J; Ovadia H
    Neuroimmunomodulation; 2016; 23(1):1-7. PubMed ID: 26670748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern.
    Dahlman I; Lorentzen JC; de Graaf KL; Stefferl A; Linington C; Luthman H; Olsson T
    Eur J Immunol; 1998 Jul; 28(7):2188-96. PubMed ID: 9692888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
    Bettelli E; Baeten D; Jäger A; Sobel RA; Kuchroo VK
    J Clin Invest; 2006 Sep; 116(9):2393-402. PubMed ID: 16955141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
    Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
    J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived gangliosides suppress the chronic relapsing-remitting experimental autoimmune encephalomyelitis in NOD mice induced with myelin oligodendrocyte glycoprotein peptide.
    Sekiguchi Y; Ichikawa M; Inoue A; Itoh M; Koh CS
    J Neuroimmunol; 2001 Jun; 116(2):196-205. PubMed ID: 11438174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
    Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.
    Peterson LK; Tsunoda I; Masaki T; Fujinami RS
    J Neuroimmunol; 2007 Feb; 183(1-2):69-80. PubMed ID: 17197039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
    Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
    Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.